Review article: effects of type 2 diabetes therapies on bone metabolism.

about

The Effects of Vitamin E from (Oil Palm) in a Rat Model of Bone Loss Due to Metabolic Syndrome

P2860

Q58703853-0E4B5498-4960-4358-BC69-1652CA28CD63

P2860

Review article: effects of type 2 diabetes therapies on bone metabolism.

Item

http://www.wikidata.org/entity/Q42363966

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Review article: effects of type 2 diabetes therapies on bone metabolism.

@en

Review article: effects of type 2 diabetes therapies on bone metabolism.

@nl

type

Item

label

Review article: effects of type 2 diabetes therapies on bone metabolism.

@en

Review article: effects of type 2 diabetes therapies on bone metabolism.

@nl

prefLabel

Review article: effects of type 2 diabetes therapies on bone metabolism.

@en

Review article: effects of type 2 diabetes therapies on bone metabolism.

@nl

P1476

Review article: effects of type 2 diabetes therapies on bone metabolism.

@en

P2093

A G D Vianna

http://www.w3.org/2001/XMLSchema#string

C P Sanches

http://www.w3.org/2001/XMLSchema#string

F C Barreto

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

Metformin revisited: Does this regulator of AMP-activated protein kinase secondarily affect bone metabolism and prevent diabetic osteopathy

Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors

Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes

Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion

Diabetes, bone and glucose-lowering agents: clinical outcomes.

The risk of fractures associated with thiazolidinediones: a self-controlled case-series study

Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial.

Osteoporosis, fractures, and diabetes.

The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.

P2888

s13098-017-0274-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13098-017-0274-5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091917100

http://www.w3.org/2001/XMLSchema#string

P698

29021829

http://www.w3.org/2001/XMLSchema#string

P932

5613523

http://www.w3.org/2001/XMLSchema#string

Review article: effects of type 2 diabetes therapies on bone metabolism.

about

P2860

P2860

Review article: effects of type 2 diabetes therapies on bone metabolism.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P6179

P698

P932